Product Offerings
Products:
Polyunsaturated Fatty Acids: DHA Algae Oil, DHA Powder, ARA Oil, ARA Powder
Zhejiang Grand Biotech Co., Ltd., headquartered in Taizhou, Zhejiang Province, is a high-tech enterprise specializing in the research, development, and production of polyunsaturated fatty acids (PUFAs), with a primary focus on docosahexaenoic acid (DHA) and arachidonic acid (ARA). The company is recognized for its innovations in microbial fermentation technology, which forms the backbone of its proprietary algae oil and powder-based nutritional products.
Founded in the early 2000s, Zhejiang Grand Biotech has established itself as a pioneer in China's biotechnology industry, specifically within the functional nutritional ingredient sector. It integrates upstream research capabilities with large-scale manufacturing and stringent quality assurance systems.
Core Business and Product Offerings
The company’s product portfolio primarily includes:
- DHA Algae Oil
- DHA Powder
- ARA Oil
- ARA Powder
These products are widely used in:
- Infant formula
- Nutritional supplements
- Functional foods and beverages
- Medical nutrition products
Zhejiang Grand Biotech is one of the few companies in China with an integrated production chain that includes fermentation, extraction, refining, microencapsulation, and powdering processes for PUFAs.
Specialization and Core USP
Zhejiang Grand Biotech’s core strengths include:
- Use of Schizochytrium sp. algae strains for high-yield DHA extraction
- Patented microencapsulation technology to ensure oxidative stability of oils and powders
- Tailored solutions for infant formula brands and food supplement manufacturers
- Strong R&D focus, including collaborations with academic institutions
The company’s R&D team has developed over 20 proprietary patents related to fermentation and microencapsulation of omega fatty acids.
Financials and Export Footprint
While the company does not publish its detailed financials publicly, data from import-export analytics platforms such as ImportYeti and Volza show that Zhejiang Grand Biotech has shipped over 500 international consignments between 2021 and 2023.
Key export markets include:
- United States
- Europe (Germany, France, Netherlands)
- Australia
- South Korea
- Japan
Its international customer base primarily includes infant nutrition brands, dietary supplement manufacturers, and B2B nutraceutical formulators.
Target Market
Zhejiang Grand Biotech targets:
- Infant nutrition companies
- Nutraceutical firms
- Health food brands
- Medical food and clinical nutrition providers
Their microencapsulated PUFA powders are particularly suited for dry formulations where shelf stability and sensory performance are critical.
Capabilities
- Fermentation capacity exceeding 1,000 tons per year
- Refinement and microencapsulation lines for both oil and powder formats
- GMP-compliant production facilities
- Custom formulation services for global clients
The company has been investing consistently in automation, cleanroom technology, and analytical laboratories to support its quality-first approach.
Certifications and Compliance
Zhejiang Grand Biotech holds a comprehensive set of international certifications, including:
- ISO9001 Quality Management System
- ISO22000 Food Safety Management
- HACCP Certification
- Halal Certification
- Kosher Certification
- Non-GMO Compliance
- China FDA Filing for Infant Use Ingredients
Their products also comply with regulatory requirements in North America, the European Union, and Asia-Pacific markets, supporting seamless international trade.
Customer Testimonials
Feedback from verified buyers on trade platforms such as Alibaba and Made-in-China consistently highlight the company’s high purity levels, technical support, and reliable supply chain management. Clients emphasize Zhejiang Grand Biotech’s responsiveness and ability to meet formulation-specific needs.
Major Achievements
- Among the first Chinese companies to industrialize DHA production via fermentation
- Holder of 20+ domestic and international patents
- Supplier to top infant nutrition and nutraceutical brands globally
- Recognized as a National High-Tech Enterprise by the Chinese government
- Successful participation in international exhibitions such as Vitafoods Europe, Hi China, and CPhI
With a blend of biotechnological innovation, scale, and regulatory compliance, Zhejiang Grand Biotech Co., Ltd. continues to solidify its position as a reliable global supplier of high-quality polyunsaturated fatty acid ingredients tailored for health and nutrition markets worldwide.